里昂发表报告指，京东健康(06618.HK) 上半年业绩符合预期，营收按年增15.9%，经调整息税前利润按年增40%。第二季营收按年增14.9%，较第一季按年17%放慢，其中药品销售强劲，但营养品与医疗器械销售较弱。随着药品销售维持25%的按年增长，且营养品销售在法规明朗化后有所改善，该行预期2026年下半年营收将加速增长，按年增长达16.7%。考量财务收益减少，该行将京东健康2026/2027...
Source Link里昂发表报告指，京东健康(06618.HK) 上半年业绩符合预期，营收按年增15.9%，经调整息税前利润按年增40%。第二季营收按年增14.9%，较第一季按年17%放慢，其中药品销售强劲，但营养品与医疗器械销售较弱。随着药品销售维持25%的按年增长，且营养品销售在法规明朗化后有所改善，该行预期2026年下半年营收将加速增长，按年增长达16.7%。考量财务收益减少，该行将京东健康2026/2027...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.